Harbour Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Harbour Investments's IBB Position: Q2 2026 in Review
Harbour Investments reduced its iShares Biotechnology ETF (IBB) stake by 6.1% in Q2 2026, selling an estimated $32K and leaving 2,840 shares worth $540K. The position accounts for 0.01% of the portfolio, ranked #1086.
Harbour Investments first reported a position in IBB in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.57M in Q1 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Harbour Investments held 2,840 shares of iShares Biotechnology ETF worth $540K as of Q2 2026.
- Harbour Investments sold 186 iShares Biotechnology ETF shares in Q2 2026, an estimated $32K.
- iShares Biotechnology ETF made up 0.01% of Harbour Investments's portfolio in Q2 2026, its #1086 holding.
- Harbour Investments first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's iShares Biotechnology ETF position peaked at $1.57M in Q1 2021.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.